Keywords: Australia, Patent review, IP protection, Innovation, AusBiotech

Australian patent length too short, says AusBiotech submission to Patent Review

Article | 24 January 2013

Trade group AusBiotech has made a submission in response to the Australian Pharmaceutical Patents Review’s Background and Suggested ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in